SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A Biotech Bash - Recs and Wrecks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Larry Liebman who wrote (45)8/27/1997 9:11:00 AM
From: Henry Niman   of 171
 
Larry, Joe Kernan has mentioned the Panretin trial HALT at least twice so far on CNBC. He explained why it would be unethical to withold the drug from the placebo group. HALT of a Phase III trial for ethical reasons is the dream outcome for a Biotech, especially a tier II biotech like LGND. This good news should help the entire sector. Last halt that I recall was Dec, 1996 when CNTO halted Reopro trial. Big Biotech rally followed. Joe Kernan just mentioned AGN and LGND again and said "they would be following it all day!"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext